Cargando…

Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut Microbiota

Treatment for moderate-to-severe acne vulgaris relies on prolonged use of oral tetracycline-class antibiotics; however, these broad-spectrum antibiotics are often associated with off-target effects and negative gastrointestinal sequelae. Sarecycline is a narrow-spectrum antibiotic treatment option....

Descripción completa

Detalles Bibliográficos
Autores principales:	Moura, Ines B., Grada, Ayman, Spittal, William, Clark, Emma, Ewin, Duncan, Altringham, James, Fumero, Emilio, Wilcox, Mark H., Buckley, Anthony M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194605/ https://www.ncbi.nlm.nih.gov/pubmed/35711781 http://dx.doi.org/10.3389/fmicb.2022.901911

Ejemplares similares

Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris
por: Moore, Angela Yen, et al.
Publicado: (2019)

The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infection
por: Buckley, Anthony M, et al.
Publicado: (2021)

Reduced blood-brain barrier penetration of acne vulgaris antibiotic sarecycline compared to minocycline corresponds with lower lipophilicity
por: Grada, Ayman, et al.
Publicado: (2022)

Sarecycline Demonstrates Clinical Effectiveness against Staphylococcal Infections and Inflammatory Dermatoses: Evidence for Improving Antibiotic Stewardship in Dermatology
por: Grada, Ayman, et al.
Publicado: (2022)

Sarecycline inhibits protein translation in Cutibacterium acnes 70S ribosome using a two-site mechanism
por: Lomakin, Ivan B, et al.
Publicado: (2023)

Sarecycline: A Review of Preclinical and Clinical Evidence
por: Moore, Angela Yen, et al.
Publicado: (2020)

Sarecycline treatment for acne vulgaris: Rationale for weight‐based dosing and limited impact of food intake on clinical efficacy
por: Grada, Ayman, et al.
Publicado: (2021)

Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris
por: Zhanel, George, et al.
Publicado: (2018)

Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and Inflammation
por: Bunick, Christopher G., et al.
Publicado: (2021)

Effect of Sarecycline on the Acne Symptom and Impact Scale and Concerns in Moderate-to-Severe Truncal Acne in Open-Label Pilot Study
por: Moore, Angela Yen, et al.
Publicado: (2023)

Sarecycline Demonstrated Reduced Activity Compared to Minocycline against Microbial Species Representing Human Gastrointestinal Microbiota
por: Ghannoum, Mahmoud A., et al.
Publicado: (2022)

MiGut: A scalable in vitro platform for simulating the human gut microbiome—Development, validation and simulation of antibiotic‐induced dysbiosis
por: Davis Birch, William A., et al.
Publicado: (2023)

Sarecycline: First Global Approval
por: Deeks, Emma D.
Publicado: (2019)

Comparison of broad-spectrum antibiotics and narrow-spectrum antibiotics in the treatment of lower extremity cellulitis
por: Almulhim, Abdulaziz Saleh, et al.
Publicado: (2018)

Correction to: Sarecycline: First Global Approval
por: Deeks, Emma D.
Publicado: (2019)

The Production of Antibiotics Must Be Reoriented: Repositioning Old Narrow-Spectrum Antibiotics, Developing New Microbiome-Sparing Antibiotics
por: Diamantis, Sylvain, et al.
Publicado: (2022)

A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development
por: Böttcher, Lucas, et al.
Publicado: (2022)

Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human Colon
por: Moura, Ines B., et al.
Publicado: (2019)

Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon
por: Moura, Ines B., et al.
Publicado: (2020)

A roadmap for designing narrow-spectrum antibiotics targeting bacterial pathogens
por: Cao, Xinyun, et al.
Publicado: (2022)

Comparative analysis of the effectiveness of narrow-spectrum versus broad-spectrum antibiotics for the treatment of childhood pneumonia
por: Demeke, Chilot Abiyu, et al.
Publicado: (2021)

Modeling Likelihood of Coverage for Narrow Spectrum Antibiotics in Patients Hospitalized with Urinary Tract Infections
por: Hebert, Courtney, et al.
Publicado: (2017)

Theoretical Development of DnaG Primase as a Novel Narrow-Spectrum Antibiotic Target
por: Periago, Jessica, et al.
Publicado: (2022)

Zolav(®): a new antibiotic for the treatment of acne
por: Dinant, Alexa, et al.
Publicado: (2016)

Antibiotic Susceptibility of Cutibacterium acnes Strains Isolated from Israeli Acne Patients
por: SHEFFER-LEVI, Sivan, et al.
Publicado: (2020)

A Post Hoc Analysis of Efficacy Data on Sarecycline in Hispanics with Acne from Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trials
por: Moore, Angela Yen, et al.
Publicado: (2023)

Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection
por: Normington, Charmaine, et al.
Publicado: (2021)

Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome
por: Batool, Zahra, et al.
Publicado: (2020)

Prescribing Trends for Acne Vulgaris Visits in the United States
por: Perche, Patrick O., et al.
Publicado: (2023)

Susceptibility of Propionibacterium acnes isolated from patients with acne vulgaris to zinc ascorbate and antibiotics
por: Iinuma, Katsuhiro, et al.
Publicado: (2011)

Non-antibiotic Isotretinoin Treatment Differentially Controls Propionibacterium acnes on Skin of Acne Patients
por: Ryan-Kewley, Angela E., et al.
Publicado: (2017)

BACTERIAL RESISTANCE TO ANTIBIOTICS IN ACNE VULGARIS: AN IN VITRO STUDY
por: Hassanzadeh, Parvin, et al.
Publicado: (2008)

Zolav(®): a new antibiotic for the treatment of acne [Corrigendum]
Publicado: (2016)

Comparative Efficacy Between Intense Pulsed Light Narrow Spectrum and Broad Spectrum in the Treatment of Post-Acne Erythema (PAE)
por: Al-Quran, Lina, et al.
Publicado: (2023)

Cross-sectional Pilot Study of Antibiotic Resistance in Propionibacterium Acnes Strains in Indian Acne Patients Using 16S-RNA Polymerase Chain Reaction: A Comparison Among Treatment Modalities Including Antibiotics, Benzoyl Peroxide, and Isotretinoin
por: Sardana, Kabir, et al.
Publicado: (2016)

2578. Narrow-Spectrum Antibiotic Treatment of Clostridium difficile Infection Improves Preservation of Intestinal Metabolic Profile
por: Park, Seoyoung, et al.
Publicado: (2019)

Under-utilization of Narrow-Spectrum Antibiotics in the Ambulatory Management of Pediatric UTI: A Single-Center Experience
por: Lee, Philip, et al.
Publicado: (2021)

Narrowing antibiotic spectrum of activity for trauma-associated pneumonia through the use of a disease-specific antibiogram
por: Ting, Michelle H, et al.
Publicado: (2021)

93. Leveraging Stewardship to Promote Narrower-spectrum Antibiotic Use for Low-risk AmpC Enterobacterales
por: Hardy, Megan E, et al.
Publicado: (2023)

In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria
por: Zhang, Tingting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_34iqu557frfmpfqi2c9p18llog